Ablative Radiotherapy in Metastatic Disease Registry - Clinical Trial
¿Cuál es el Propósito de este estudio?
We are doing this study to collect information about people with oligometastasis for future use.
¿Cuál es la Condición que se está estudiando?
Oligometastasis (Cancer That Has Spread to 1 or 2 Other Parts of the Body)
¿Quién puede participar en el Estudio?
Adults who:
- Have cancer that has spread to other parts of the body
- Are planning to undergo ablative radiotherapy
For more information, contact the study team at taylor.fryman@duke.edu.
Grupo etario
Adultos
¿Qué Implica?
If you decide to join this study, you will come in for one visit to let us collect data about you, your disease, and your treatment.
Detalles del Estudio
Título Completo
Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Investigador Principal
Joseph K. Salama, MD
Especialista en oncología radioterápica
Número de Protocolo
IRB:
PRO00103137
NCT:
NCT04085029
Fase
Fase N/A
ClinicalTrials.gov
Ver en ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción